Byeong Keon Son, president of Wuestec, is taking over the post of CEO. The expansion of duties, described by the company as a major corporate repositioning, puts Son in charge of Wuestec's strategic direction, product development, distribution, and
Byeong Keon Son, president of Wuestec, is taking over the post of CEO. The expansion of duties, described by the company as a major corporate repositioning, puts Son in charge of Wuestec's strategic direction, product development, distribution, and financial performance. Son joined Wuestec as president in 2000. Before then, he was in charge of strategic development at Gemini Consulting in New York.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.